Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2

BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) posed an enormous threat to public health. The use of antiviral drugs in patients with this disease have triggered people’s attentions. Whether interferon alfa-2b or lopinavir/ritonavir (LPV/r) plus interferon alfa-2b treatment can agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingyuan, Du, Chunjing, Pu, Lin, Xiang, Pan, Xiong, Haofeng, Xie, Wen, Chen, Zhihai, Li, Ang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404023/
https://www.ncbi.nlm.nih.gov/pubmed/34461841
http://dx.doi.org/10.1186/s12879-021-06595-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404023/
https://www.ncbi.nlm.nih.gov/pubmed/34461841
http://dx.doi.org/10.1186/s12879-021-06595-6

Ejemplares similares